Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Hormonal agents from Yamanouchi

Nov. 8, 1996

Ilex compound for malignant brain tumors licensed to Janssen

Nov. 8, 1996

New taxane series disclosed by Indena

Nov. 8, 1996

Univ. of Tokyo researchers identify new antitumor antibiotics

Nov. 8, 1996

Novel piericidin antitumor antibiotics reported by Japanese and Chinese researchers

Nov. 8, 1996

Meiji Seika discloses antitumor antibiotics

Nov. 8, 1996

IND filing for SPI-77

Nov. 8, 1996

Debiopharm describes novel platinum complexes

Nov. 8, 1996

Hybridon's 1729 for multi-drug-resistant cancers

Nov. 1, 1996

New synthetic process for swainsonine should facilitate clinical testing

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...